SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Tularik Inc. (TLRK)
An SI Board Since October 1999
Posts SubjectMarks Bans Symbol
598 27 0 TLRK
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
423form 4, looks to me like Goeddel bought 10K shares, 1/31/03. (eom)scaram(o)uche-2/4/2003
422Lyle surfaces at Edwards Lifesciences, where she was a Director. Sort of differscaram(o)uche-2/3/2003
421I was surprised that Thymatiq could qualify for Orphan Drug status. I would havCzechsinthemail-2/3/2003
420Ah - thought the name sounded vaguely familiar, but I didn't connect it withBiomaven-2/3/2003
419>> Never previously heard of this drug or Eximias - they are privately helscaram(o)uche-2/3/2003
418Thanks, Baird. Guess it's a gamble on whether upping the dose will jack up tBiomaven-2/2/2003
417Peter, Looks like no one has responded to your request. Here's what I caCzechsinthemail-2/2/2003
416If I remember correctly Rick someone was dumping NBIX to help send NBIX to $4...EVENT HORIZON III-1/31/2003
415I (fortunately) haven't owned the stock in a long while, and I want to get uBiomaven-1/30/2003
414There seems to be some discrepancy on the USB Piper Jaffray Conference. TularikCzechsinthemail-1/30/2003
413McKnight's sales explains where some of the shares came from on the recent dCzechsinthemail-1/30/2003
412>> It will be a roller-coaster... << Nobody warned me to watch for scaram(o)uche-1/29/2003
411>>...a 1998 business plan into a 2002 biotech world. It just hasn't womopgcw-1/29/2003
410Thanks, very much, for that! Rickscaram(o)uche-1/29/2003
409GS take on the quarter: Stock rating: In-Line Coverage view: Neutral TLRK repomopgcw-1/29/2003
408Yes? (eom)scaram(o)uche-1/29/2003
407I saw that and worried first it was an option contract, a la ttp. But the appeakeokalani'nui-1/29/2003
406>> His shareholders who bought into this quiet confidence or not-overt arrscaram(o)uche-1/29/2003
405form 4 filed for McKnight..... eyeballing, it looks like he dumped about 500K sscaram(o)uche-1/29/2003
404Goeddel, running alone down the path that he couldn't sell to investors, 607scaram(o)uche-1/29/2003
403>So the company will need cash, soon...< At JPM conference, indicated enufred hayes-1/29/2003
402Actually, we may hear some interesting things from TLRK, but it is likely to be Czechsinthemail-1/29/2003
401I had not noticed earlier, $20m cash belongs to a consolidated subsidiary. Exckeokalani'nui-1/29/2003
400mopgcw, Thanks for the CC notes. One small correction: I believe they forecCzechsinthemail-1/29/2003
399CC summary: 2 new compounds in clinic; 4 tlrk discoverd in clinic + 2 partnemopgcw-1/29/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News